CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+17.6%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.89B
AUM Growth
+$1.89B
(+9.7%)
Cap. Flow
-$15.2M
Cap. Flow
% of AUM
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
59.01%
Holding
53
New
4
Increased
8
Reduced
11
Closed
6
Top Buys
| 1 |
BIOA
BioAge Labs, Inc. Common Stock
BIOA
|
$33.9M |
| 2 |
Avidity Biosciences
RNA
|
$28.7M |
| 3 |
MBX
MBX Biosciences, Inc. Common Stock
MBX
|
$18.2M |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$15.2M |
| 5 |
AnaptysBio
ANAB
|
$11.5M |
Top Sells
| 1 |
Arcellx
ACLX
|
$23M |
| 2 |
Biohaven
BHVN
|
$20M |
| 3 |
Sarepta Therapeutics
SRPT
|
$19.8M |
| 4 |
Cullinan Oncology
CGEM
|
$19.6M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-2,600,000
| Closed | -$5.23M |
|
52
SIGA Technologies
SIGA
$617M
| – | – |
0
| – | – |
|
|
53
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-125,000
| Closed | -$19.8M |
|